BioCentury
PODCAST | Politics, Policy & Law

Where China’s Hatch-Waxman Act falls short: a BioCentury podcast

A conversation with Jones Day’s Tony Chen on the latest IP reforms in China 

November 7, 2020 2:24 AM UTC

Long-awaited pharmaceutical provisions included in China’s patent law fall short of what innovators had hoped for, Jones Day’s Tony Chen said on the latest BioCentury This Week – Special Edition podcast. 

Chen, a partner in the firm’s Shanghai office, joined Associate Editor Virginia Li to discuss his latest commentary in BioCentury on China’s recent IP reforms, which introduced a patent linkage system and patent term extensions designed to protect pharmaceutical innovations from generic challengers. ...